How to Test Human-Specific Combination Immunotherapies In Vivo

Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine: Molecular Therapy - Methods & Clinical Development

Frontiers Clinical cancer immunotherapy: Current progress and prospects

Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy - Yang - 2023 - Advanced Science - Wiley Online Library

The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial - eBioMedicine

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations

Multimodal analysis for human ex vivo studies shows extensive molecular changes from delays in blood processing - ScienceDirect

A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses - ScienceDirect

Frontiers In vivo Imaging Technologies to Monitor the Immune System

Beginners Guide to PBMC Humanized Tumor Models

Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo

In vivo gene immunotherapy for cancer

Gemcitabine in the Era of Cancer Immunotherapy

Cancers, Free Full-Text

Steps involved in establishing human immune system (HIS) models in

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases - eBioMedicine